22 related articles for article (PubMed ID: 17352211)
1. Clinical contribution of bcl-2, p53 and Ki-67 proteins in pancreatic ductal adenocarcinoma.
Mäkinen K; Hakala T; Lipponen P; Alhava E; Eskelinen M
Anticancer Res; 1998; 18(1B):615-8. PubMed ID: 9568186
[TBL] [Abstract][Full Text] [Related]
2. Of humans and canines: Immunohistochemical analysis of PCNA, Bcl-2, p53, cytokeratin and ER in mammary tumours.
Kumaraguruparan R; Prathiba D; Nagini S
Res Vet Sci; 2006 Oct; 81(2):218-24. PubMed ID: 16740286
[TBL] [Abstract][Full Text] [Related]
3. Bcl-2 expression related to altered p53 protein and its impact on the progression of human pancreatic carcinoma.
Hu YX; Watanabe H; Ohtsubo K; Yamaguchi Y; Ha A; Motoo Y; Okai T; Sawabu N
Br J Cancer; 1999 Jun; 80(7):1075-9. PubMed ID: 10362119
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of expression of p21 and p53 proteins and proliferating cell nuclear antigen in pancreatic cancer.
Dang CX; Han Y; Qin ZY; Wang YJ
Hepatobiliary Pancreat Dis Int; 2002 May; 1(2):302-5. PubMed ID: 14612290
[TBL] [Abstract][Full Text] [Related]
5. Bcl-2 and proliferating cell nuclear antigen (PCNA) expression correlates with subsequent local recurrence in nasopharyngeal carcinomas.
Tsai ST; Jin YT; Leung HW; Wang ST; Tsao CJ; Su IJ
Anticancer Res; 1998; 18(4B):2849-54. PubMed ID: 9713473
[TBL] [Abstract][Full Text] [Related]
6. What have animal models taught us about the p53 pathway?
Lozano G; Zambetti GP
J Pathol; 2005 Jan; 205(2):206-20. PubMed ID: 15643668
[TBL] [Abstract][Full Text] [Related]
7. Models of pancreatic cancer.
Hall PA; Lemoine NR
Cancer Surv; 1993; 16():135-55. PubMed ID: 8348533
[TBL] [Abstract][Full Text] [Related]
8. Endocrine tumours of the gastrointestinal tract: aetiology, molecular pathogenesis and genetics.
Rindi G; Bordi C
Best Pract Res Clin Gastroenterol; 2005 Aug; 19(4):519-34. PubMed ID: 16183525
[TBL] [Abstract][Full Text] [Related]
9. Tumour suppressor protein (p53), apoptosis inhibiting protein (Bcl-2) and proliferating cell nuclear antigen (PCNA) expressions in a rat pancreatic tumour model.
Mäkinen K; Loimas S; Hakala T; Eskelinen M
Anticancer Res; 2007; 27(1A):23-6. PubMed ID: 17352211
[TBL] [Abstract][Full Text] [Related]
10. The value of immunohistochemical research on PCNA, p53 and heat shock proteins in prostate cancer management: a review.
Cappello F; Ribbene A; Campanella C; Czarnecka AM; Anzalone R; Bucchieri F; Palma A; Zummo G
Eur J Histochem; 2006; 50(1):25-34. PubMed ID: 16584982
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
